MIST PPF Study now enrolling

Learn More

Phase 1b ATLAS Study

A Randomized Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis

Read Our Publication